Arkolith/Insider Trading/TECX/Form 4

Reicin Alise

Chief Executive Officer, DirectorTectonic Therapeutic, Inc. (TECX) · full profile →Form 4 · filed Jun 24, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
5
2 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 20, 2024Grant(A)167K——167K
Jun 20, 2024Grant(A)125K——125K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 20, 2024Grant(A)34K——34K
Jun 20, 2024Grant(A)290K—$0290K
Jun 20, 2024Grant(A)23K——23K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-24-017952) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML